continuous glucose monitoring performance evaluations (International Federation of Clinical Chemistry and Laboratory Medicine)
90
Structured Review
International Federation of Clinical Chemistry and Laboratory Medicine
continuous glucose monitoring performance evaluations
Continuous Glucose Monitoring Performance Evaluations, supplied by International Federation of Clinical Chemistry and Laboratory Medicine, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Performance+Monitoring/continuous+glucose+monitoring/pm38528741-8-3-11
Average 90 stars, based on 1 article reviews
Continuous Glucose Monitoring Performance Evaluations, supplied by International Federation of Clinical Chemistry and Laboratory Medicine, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Performance+Monitoring/continuous+glucose+monitoring/pm38528741-8-3-11
Average 90 stars, based on 1 article reviews
continuous glucose monitoring performance evaluations - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems. Article Snippet: Comparing the performance of different continuous glucose monitoring (CGM) systems is challenging due to the lack of comprehensive guidelines for clinical study design.. In particular, the absence of concise requirements for the distribution of comparator (reference) blood glucose (BG) concentrations and their rate of change (RoC) that are used to evaluate CGM performance, impairs comparability.. For this article, several experts in the field of CGM performance testing have collaborated to propose characteristics of the distribution of comparator measurements that should be collected during CGM performance testing. Article Title: Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—‘ eCGM ’ compliance status Article Snippet: The requirement for more rigorous CGM device regulation is accepted and, for the medium‐to‐long term, the International Federation of Clinical Chemistry and Laboratory Article Title: Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGM. Article Snippet: In a recent commentary by Mathieu et al. in Diabetes, Obesity and Metabolism, a group of clinical diabetes experts proposed minimum expectations for market authorisation of continuous glucose monitoring (CGM) systems in Europe.. The need for such requirements in Europe was motivated by citing several recent incidents where using CE-marked CGM systems or automated insulin delivery (AID) systems with poor real-life performance led to negative consequences for patients.. In this letter, we, the members of the Working Group on CGM established by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), would like to provide our viewpoint on the current situation in Europe and discuss the proposal by Mathieu et al. in more detail. Article Title: Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings. Article Snippet: The authors thank the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Article Title: Minimum requirements for continuous glucose monitors: What does it mean? Article Snippet: The U.S. Food and Drug Administration (FDA) 510(k) approval of laboratory medicine assays has always been consistent.1 Manufacturers submit data according to a series of protocols.. The two most important parameters are bias and precision.. Clinical & Laboratory Standards Institute protocols are typically used (EP9 for bias and EP5 for precision). Article Title: Diabetes Technology Meeting 2023. Article Snippet: Symposium: Article Title: Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems Article Snippet: This article is a proposal from the Working Group on Article Title: Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting. Article Snippet: Abbreviations ARD, absolute relative difference; BGMS, blood glucose monitoring system; CG-EGA, continuous glucose error grid analysis; CGM, continuous glucose monitoring; FDA, U.S. Food and |